ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
117 hedge funds and large institutions have $346M invested in ChemoCentryx, Inc. in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 55 increasing their positions, 32 reducing their positions, and 17 closing their positions.
72% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 32
12% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 17
0% more funds holding
Funds holding: 117 → 117 (0)
26% less capital invested
Capital invested by funds: $469M → $346M (-$123M)
57% less call options, than puts
Call options by funds: $2.46M | Put options by funds: $5.71M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$15.5M |
| 2 |
BlackRock
New York
|
+$13.9M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$6.25M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$5.79M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
-$6.14M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.56M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$3.47M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$2.58M |
| 5 |
SIM
Spark Investment Management
New York
|
-$1.96M |
CCXI Hedge Fund Activity: Q2 2019 in Review
117 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q2 2019, worth a combined $346M — down 26% from $469M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new CCXI positions and 17 closed out — a net gain of 2 holders — while 55 added to existing stakes and 32 trimmed.
The largest buyer was State Street, adding an estimated $15.5M. The largest seller was Sio Capital Management, exiting entirely with an estimated $6.14M sold.
- 117 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $346M of ChemoCentryx, Inc. stock for Q2 2019, down 26% quarter-over-quarter.
- 19 funds opened new ChemoCentryx, Inc. positions in Q2 2019 and 17 closed out, a net change of +2 holders.
- The largest ChemoCentryx, Inc. buyer in Q2 2019 was State Street, an estimated $15.5M added.
- The largest ChemoCentryx, Inc. seller in Q2 2019 was Sio Capital Management, an estimated $6.14M sold.
Based on aggregated 13F filings for Q2 2019.